B. A. J. Veldman

662 total citations
15 papers, 482 citations indexed

About

B. A. J. Veldman is a scholar working on Surgery, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. A. J. Veldman has authored 15 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Nephrology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. A. J. Veldman's work include Chronic Kidney Disease and Diabetes (2 papers), Dialysis and Renal Disease Management (2 papers) and Blood Pressure and Hypertension Studies (2 papers). B. A. J. Veldman is often cited by papers focused on Chronic Kidney Disease and Diabetes (2 papers), Dialysis and Renal Disease Management (2 papers) and Blood Pressure and Hypertension Studies (2 papers). B. A. J. Veldman collaborates with scholars based in Netherlands, United States and Chile. B. A. J. Veldman's co-authors include Paul Smits, Gerald Vervoort, Wilko Spiering, Peter W. de Leeuw, Abraham A. Kroon, P. A. Doevendans, Jack F.M. Wetzels, Griet Vervoort, Jo H. M. Berden and M.W.I.M. Horstink and has published in prestigious journals such as Nephrology Dialysis Transplantation, Journal of Hypertension and British Journal of Clinical Pharmacology.

In The Last Decade

B. A. J. Veldman

15 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. A. J. Veldman Netherlands 9 117 112 106 82 66 15 482
Janusz Solski Poland 14 143 1.2× 59 0.5× 53 0.5× 54 0.7× 94 1.4× 64 540
Nathalie Baudry France 15 134 1.1× 108 1.0× 88 0.8× 56 0.7× 36 0.5× 27 574
Dmitri Belov United States 5 280 2.4× 90 0.8× 117 1.1× 253 3.1× 77 1.2× 8 903
Guangda Xiang China 13 226 1.9× 103 0.9× 128 1.2× 188 2.3× 31 0.5× 34 627
Franco B. Mueller United States 14 162 1.4× 85 0.8× 217 2.0× 106 1.3× 111 1.7× 21 725
Gurdip Daffu United States 9 134 1.1× 82 0.7× 38 0.4× 111 1.4× 25 0.4× 11 508
Mark Cukiernik Canada 12 231 2.0× 134 1.2× 121 1.1× 43 0.5× 25 0.4× 14 542
Jiro Kitayama Japan 10 61 0.5× 92 0.8× 92 0.9× 42 0.5× 65 1.0× 21 411
Jung-Nan Wei Taiwan 11 182 1.6× 81 0.7× 75 0.7× 79 1.0× 43 0.7× 12 432
Clotilde Zoukourian France 4 124 1.1× 202 1.8× 60 0.6× 293 3.6× 71 1.1× 5 764

Countries citing papers authored by B. A. J. Veldman

Since Specialization
Citations

This map shows the geographic impact of B. A. J. Veldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. A. J. Veldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. A. J. Veldman more than expected).

Fields of papers citing papers by B. A. J. Veldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. A. J. Veldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. A. J. Veldman. The network helps show where B. A. J. Veldman may publish in the future.

Co-authorship network of co-authors of B. A. J. Veldman

This figure shows the co-authorship network connecting the top 25 collaborators of B. A. J. Veldman. A scholar is included among the top collaborators of B. A. J. Veldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. A. J. Veldman. B. A. J. Veldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Veldman, B. A. J., et al.. (2020). Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients. International Journal of Clinical Pharmacy. 42(3). 965–971. 1 indexed citations
2.
Heijden, Charlotte D.C.C. van der, et al.. (2019). Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia. British Journal of Clinical Pharmacology. 85(12). 2886–2890. 11 indexed citations
3.
Herwaarden, Noortje van, Jacqueline M. Bos, B. A. J. Veldman, & Cornelis Kramers. (2018). [Proton pump inhibitors: not as safe as they seem].. PubMed. 160. D487–D487. 3 indexed citations
4.
Schipper, L.G., et al.. (2015). Treatment of osteoporosis in renal insufficiency. Clinical Rheumatology. 34(8). 1341–1345. 15 indexed citations
5.
Rops, Angelique L., M.J. van den Hoven, B. A. J. Veldman, et al.. (2011). Urinary heparanase activity in patients with Type 1 and Type 2 diabetes. Nephrology Dialysis Transplantation. 27(7). 2853–2861. 39 indexed citations
6.
Schouwenberg, Bas, B. A. J. Veldman, Wilko Spiering, et al.. (2008). The Arg16Gly variant of the β2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus. Pharmacogenetics and Genomics. 18(4). 369–372. 9 indexed citations
7.
Gilles, R., et al.. (2008). Measurement of leg blood pressure: the most straightforward way to the diagnosis.. PubMed. 66(2). 81–4. 2 indexed citations
8.
Veldman, B. A. J., Paul E. Verweij, & Nicole Blijlevens. (2006). Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation.. PubMed. 64(4). 127–9. 1 indexed citations
9.
Veldman, B. A. J., et al.. (2005). Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance. Diabetic Medicine. 22(3). 301–305. 29 indexed citations
10.
Vervoort, Griet, B. A. J. Veldman, Jo H. M. Berden, Paul Smits, & Jack F.M. Wetzels. (2005). Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. European Journal of Clinical Investigation. 35(5). 330–336. 61 indexed citations
11.
Veldman, B. A. J., et al.. (2004). Pharmacodynamics of L-NMMA in Type 1 Diabetes Patients and Control Subjects. Journal of Cardiovascular Pharmacology. 44(2). 231–234. 3 indexed citations
12.
Veldman, B. A. J., et al.. (2003). Low concentrations of intravenous polygelines promote low‐molecular weight proteinuria. European Journal of Clinical Investigation. 33(11). 962–968. 24 indexed citations
13.
Veldman, B. A. J., Wilko Spiering, P. A. Doevendans, et al.. (2002). The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. Journal of Hypertension. 20(10). 2023–2027. 215 indexed citations
14.
Veldman, B. A. J. & Griet Vervoort. (2002). Pathogenesis of renal microvascular complications in diabetes mellitus.. PubMed. 60(10). 390–6. 3 indexed citations
15.
Veldman, B. A. J., et al.. (1998). Genetic and environmental risk factors in Parkinson’s disease. Clinical Neurology and Neurosurgery. 100(1). 15–26. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026